197 related articles for article (PubMed ID: 30258911)
1. Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor.
Wu D
Genes Dis; 2017 Jun; 4(2):100-107. PubMed ID: 30258911
[TBL] [Abstract][Full Text] [Related]
2. EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.
Zhang S; Wang X; Osunkoya AO; Iqbal S; Wang Y; Chen Z; Müller S; Chen Z; Josson S; Coleman IM; Nelson PS; Wang YA; Wang R; Shin DM; Marshall FF; Kucuk O; Chung LW; Zhau HE; Wu D
Oncogene; 2011 Dec; 30(50):4941-52. PubMed ID: 21625216
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.
Zhang S; Wang X; Iqbal S; Wang Y; Osunkoya AO; Chen Z; Chen Z; Shin DM; Yuan H; Wang YA; Zhau HE; Chung LW; Ritenour C; Kucuk O; Wu D
J Biol Chem; 2013 Jan; 288(3):1469-79. PubMed ID: 23188829
[TBL] [Abstract][Full Text] [Related]
4. Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model.
Wu D; Osunkoya AO; Kucuk O
Am J Clin Exp Urol; 2021; 9(4):264-276. PubMed ID: 34541025
[TBL] [Abstract][Full Text] [Related]
5. EPLIN: a fundamental actin regulator in cancer metastasis?
Collins RJ; Jiang WG; Hargest R; Mason MD; Sanders AJ
Cancer Metastasis Rev; 2015 Dec; 34(4):753-64. PubMed ID: 26350886
[TBL] [Abstract][Full Text] [Related]
6. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
7. Epithelial Protein Lost in Neoplasm alpha (Eplin-alpha) is transcriptionally regulated by G-actin and MAL/MRTF coactivators.
Leitner L; Shaposhnikov D; Descot A; Hoffmann R; Posern G
Mol Cancer; 2010 Mar; 9():60. PubMed ID: 20236507
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.
Song Y; Maul RS; Gerbin CS; Chang DD
Mol Biol Cell; 2002 Apr; 13(4):1408-16. PubMed ID: 11950948
[TBL] [Abstract][Full Text] [Related]
10. Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro.
Chervin-Pétinot A; Courçon M; Almagro S; Nicolas A; Grichine A; Grunwald D; Prandini MH; Huber P; Gulino-Debrac D
J Biol Chem; 2012 Mar; 287(10):7556-72. PubMed ID: 22194609
[TBL] [Abstract][Full Text] [Related]
11. EPLIN, epithelial protein lost in neoplasm.
Maul RS; Chang DD
Oncogene; 1999 Dec; 18(54):7838-41. PubMed ID: 10618726
[TBL] [Abstract][Full Text] [Related]
12. Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers.
Zeng J; Jiang WG; Sanders AJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356662
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis.
Lindell E; Zhang X
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732188
[TBL] [Abstract][Full Text] [Related]
14. EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance.
Gong W; Zeng J; Ji J; Jia Y; Jia S; Sanders AJ; Jiang WG
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33917939
[TBL] [Abstract][Full Text] [Related]
15. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments.
Maul RS; Song Y; Amann KJ; Gerbin SC; Pollard TD; Chang DD
J Cell Biol; 2003 Feb; 160(3):399-407. PubMed ID: 12566430
[TBL] [Abstract][Full Text] [Related]
16. EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance.
Zeng J; Sanders AJ; Ye L; Hargest R; Ruge F; Jiang WG
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499558
[TBL] [Abstract][Full Text] [Related]
17. EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y; Sanders AJ; Zhang L; Jiang WG
Anticancer Res; 2012 Apr; 32(4):1283-9. PubMed ID: 22493360
[TBL] [Abstract][Full Text] [Related]
18. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
19. Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm.
Chen NP; Uddin B; Hardt R; Ding W; Panic M; Lucibello I; Kammerer P; Ruppert T; Schiebel E
Proc Natl Acad Sci U S A; 2017 May; 114(20):5201-5206. PubMed ID: 28465438
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mouse epithelial protein lost in neoplasm (EPLIN) and comparison of mammalian and zebrafish EPLIN.
Maul RS; Sachi Gerbin C; Chang DD
Gene; 2001 Jan; 262(1-2):155-60. PubMed ID: 11179679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
